KFU. Card publication. The Influence of Diabetes Mellitus Duration and Type of Therapy on Cognitive Decline.

KAZAN
FEDERAL UNIVERSITY

- RUS
- 中文
- ES

THE INFLUENCE OF DIABETES MELLITUS DURATION AND TYPE OF THERAPY ON COGNITIVE DECLINE.

Form of presentation

Articles in international journals and collections

Year of publication

2016

��

��

Authors, employees of KFU

Esin Oleg Radievich, author

Esin Radiy Germanovich, author

Khayrullin Ilshat Khamzovich, author

Other authors

Abakumova Anna Aleksandrovna, author

Bibliographic description in the original language

Khairullin I., Abakumova A., Esin R., Esin O. The Influence of Diabetes Mellitus Duration and Type of Therapy on Cognitive Decline. BioNanoSci. (2016). doi:10.1007/s12668-016-0345-3

Annotation

We studied 120 patients with compensated diabetes mellitus type 2 (DM-2). The inclusion criterion was the absence of memory loss complaints from the patient and/or his/her relatives. The exclusion criteria were diabetes decom?pensation, myocardial infarction and/or stroke in anamnesis, glomerular filtration rate below 60 ml/min, the presence of proliferative retinopathy, and/or other endocrine diseases. To diagnose the cognitive decline (CD) we used Mini-Mental State Examination (MMSE), the Montreal Cognitive Assessment (MoCA test), Trail Making Test (parts A and B). 77.5 % patients with type 2 diabetes out of 120 had mod?erate CD; 5 % had a significant CD (dementia).

Keywords

Diabetes mellitus type 2, Diabetic encephalopathy, Cognitive decline, Dementia, Insulin resistance

The name of the journal

BioNanoScience

Please use this ID to quote from or refer to the card

https://repository.kpfu.ru/eng/?p_id=144718&p_lang=2

Full metadata record

Field DC	Value	Language
dc.contributor.author	Esin Oleg Radievich	ru_RU
dc.contributor.author	Esin Radiy Germanovich	ru_RU
dc.contributor.author	Khayrullin Ilshat Khamzovich	ru_RU
dc.contributor.author	Abakumova Anna Aleksandrovna	ru_RU
dc.date.accessioned	2016-01-01T00:00:00Z	ru_RU
dc.date.available	2016-01-01T00:00:00Z	ru_RU
dc.date.issued	2016	ru_RU
dc.identifier.citation	Khairullin I., Abakumova A., Esin R., Esin O. The Influence of Diabetes Mellitus Duration and Type of Therapy on Cognitive Decline. BioNanoSci. (2016). doi:10.1007/s12668-016-0345-3	ru_RU
dc.identifier.uri	https://repository.kpfu.ru/eng/?p_id=144718&p_lang=2	ru_RU
dc.description.abstract	BioNanoScience	ru_RU
dc.description.abstract	We studied 120 patients with compensated diabetes mellitus type 2 (DM-2). The inclusion criterion was the absence of memory loss complaints from the patient and/or his/her relatives. The exclusion criteria were diabetes decom?pensation, myocardial infarction and/or stroke in anamnesis, glomerular filtration rate below 60 ml/min, the presence of proliferative retinopathy, and/or other endocrine diseases. To diagnose the cognitive decline (CD) we used Mini-Mental State Examination (MMSE), the Montreal Cognitive Assessment (MoCA test), Trail Making Test (parts A and B). 77.5 % patients with type 2 diabetes out of 120 had mod?erate CD; 5 % had a significant CD (dementia).	ru_RU
dc.language.iso	ru	ru_RU
dc.subject	Diabetes mellitus type 2	ru_RU
dc.subject	Diabetic encephalopathy	ru_RU
dc.subject	Cognitive decline	ru_RU
dc.subject	Dementia	ru_RU
dc.subject	Insulin resistance	ru_RU
dc.title	The Influence of Diabetes Mellitus Duration and Type of Therapy on Cognitive Decline.	ru_RU
dc.type	Articles in international journals and collections	ru_RU